BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:15 PM
 | 
Jun 25, 2010
 |  BC Extra  |  Company News

NICE issues final appraisal for RA drugs

The U.K.'s NICE issued a final appraisal determination for five drugs to treat rheumatoid arthritis (RA) after treatment with a TNF inhibitor has failed. NICE reiterated its recommendation in favor of MabThera rituximab, a mAb against CD20 from Roche (SIX:ROG; OTCQX:RHHBY),...

Read the full 202 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >